Results 31 to 40 of about 28,034 (103)

Trifarotene: A Novel Therapeutic Option for Acne

open access: yesDermatology Research and Practice, 2022
Acne vulgaris, or acne, is a prevailing cutaneous predicament that customarily crops up on the face, neck, and trunk in the forms of comedones, papules, pustules, and nodules.
Piyu Parth Naik
doaj   +1 more source

Management of truncal acne with oral sarecycline: pooled results from two Phase 3 clinical trials

open access: yes, 2022
Background: Acne vulgaris is a common skin disease that affects the face, chest, and back. While truncal acne is present in at least 50 percent of patients, clinical studies have focused predominantly on facial acne.1 , 2 Few treatments to date have been
Zeichner, Joshua   +7 more
core   +1 more source

Identifying acne treatment uncertainties via a James Lind Alliance Priority Setting Partnership [PDF]

open access: yes, 2015
Objectives: The Acne Priority Setting Partnership (PSP) was set up to identify and rank treatment uncertainties by bringing together people with acne, and professionals providing care within and beyond the National Health Service (NHS). Setting: The
Whitehouse, H   +25 more
core   +1 more source

Acne resolution rates: Results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara (R)) and EE/LNG (Microgynon (R)) [PDF]

open access: yes, 2001
Background and Objective: Acne in women can often be successfully treated by the intake of oral contraceptives containing gestagens with anti-androgenic properties.
Zahradnik, H. P.   +4 more
core   +1 more source

Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts (supplementary information)

open access: yes, 2021
Supplementary information to: Tan J, et al. Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts. Submitted to JAAD International 2021. • Full list of consensus statements reached with voting
Expert Consensus, P (via Mendeley Data)
core   +1 more source

Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris

open access: yesTherapeutics and Clinical Risk Management, 2021
Caitlin M Brumfiel,1 Meera H Patel,2 Katheryn A Bell,1 Michael A Cardis3 1Georgetown University School of Medicine, Washington, DC, USA; 2Creighton University School of Medicine, Phoenix Regional Campus, Phoenix, AZ, USA; 3MedStar Washington Hospital ...
Brumfiel CM   +3 more
doaj  

A rare case of ectopic ACTH syndrome originating from malignant renal paraganglioma

open access: yesArchives of Endocrinology and Metabolism, 2017
SUMMARY Ectopic adrenocorticotropic hormone (ACTH) syndrome is characterized by hypercortisolism due to the hypersecretion of a non-pituitary ACTH-secreting tumor leading to Cushing’s syndrome.
Esra Tutal   +7 more
doaj   +1 more source

Efficacy and Safety of Novel 1% Hydrogen Peroxide Formulations for the Treatment of Mild-to-Moderate Facial and Truncal Acne Vulgaris

open access: yesCosmetics
Acne vulgaris remains a common condition, with current topical therapies often limited by suboptimal efficacy and tolerability. This study evaluated the efficacy and safety of two novel 1% hydrogen peroxide (H2O2) formulations, a cream-gel for facial and
Helena Martínez   +7 more
doaj   +1 more source

Truncal Acne: A Neglected Entity

open access: yes, 2019
Truncal acne – acne vulgaris involving the chest, back, or shoulders – is thought to be present in more than half of patients with acne. Because the study of acne has been focused on the face, there are sparse data in the literature about the clinical ...
Del Rosso, James Q   +4 more
core   +1 more source

Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 385-393, June 2026.
ABSTRACT In recent years, innovative topical medications with novel mechanisms of action have emerged to treat common dermatologic conditions such as acne, atopic dermatitis, vitiligo, and actinic keratoses. These molecularly targeted therapies offer improved safety and tolerability compared to traditional options like corticosteroids.
Mary Dyson   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy